Metabolic Challenges in Anticancer CD8 T Cell Functions

키워드

참고문헌 (99)

1. Martinez M, "CAR T cells for solid tumors : new strategies for finding, infiltrating, and surviving in the tumor microenvironment", Front Immunol, 10, pp.128~ (2019)
2. Liu G, "Enhancing CAR-T cell efficacy in solid tumors by targeting the tumor microenvironment", Cell Mol Immunol, 18, pp.1085~1095 (2021)
3. Martínez-Reyes I, "Cancer metabolism : looking forward", Nat Rev Cancer, 21, pp.669~680 (2021)
4. Vander Heiden MG, "Understanding the Warburg effect : the metabolic requirements of cell proliferation", Science, 324, pp.1029~1033 (2009)
5. Scharping NE, "The tumor microenvironment represses T Cell mitochondrial biogenesis to drive intratumoral T cell metabolic insufficiency and dysfunction", Immunity, 45, pp.374~388 (2016)
6. Chang CH, "Metabolic competition in the tumor microenvironment is a driver of cancer progression", Cell, 162, pp.1229~1241 (2015)
7. Vardhana SA, "Impaired mitochondrial oxidative phosphorylation limits the self-renewal of T cells exposed to persistent antigen", Nat Immunol, 21, pp.1022~1033 (2020)
8. Yu YR, "Disturbed mitochondrial dynamics in CD8+ TILs reinforce T cell exhaustion", Nat Immunol, 21, pp.1540~1551 (2020)
9. Ledderose C, "Purinergic P2X4 receptors and mitochondrial ATP production regulate T cell migration", J Clin Invest, 128, pp.3583~3594 (2018)
10. Sukumar M, "Mitochondrial membrane potential identifies cells with enhanced stemness for cellular therapy", Cell Metab, 23, pp.63~76 (2016)
11. Sena LA, "Mitochondria are required for antigen-specific T cell activation through reactive oxygen species signaling", Immunity, 38, pp.225~236 (2013)
12. Pearce EL, "Fueling immunity : insights into metabolism and lymphocyte function", Science, 342, pp.1242454~ (2013)
13. Wang R, "Metabolic checkpoints in activated T cells", Nat Immunol, 13, pp.907~915 (2012)
14. Reina-Campos M, "CD8+ T cell metabolism in infection and cancer", Nat Rev Immunol, 21, pp.718~738 (2021)
15. Buck MD, "T cell metabolism drives immunity", J Exp Med, 212, pp.1345~1360 (2015)
16. van der Windt GJ, "Metabolic switching and fuel choice during T-cell differentiation and memory development", Immunol Rev, 249, pp.27~42 (2012)
17. Nolfi-Donegan D, "Mitochondrial electron transport chain : Oxidative phosphorylation, oxidant production, and methods of measurement", Redox Biol, 37, pp.101674~ (2020)
18. Frauwirth KA, "The CD28 signaling pathway regulates glucose metabolism", Immunity, 16, pp.769~777 (2002)
19. Menk AV, "Early TCR signaling induces rapid aerobic glycolysis enabling distinct acute T cell effector functions", Cell Rep, 22, pp.1509~1521 (2018)
20. MacIver NJ, "Metabolic regulation of T lymphocytes", Annu Rev Immunol, 31, pp.259~283 (2013)
21. Carr EL, "Glutamine uptake and metabolism are coordinately regulated by ERK", MAPK during T lymphocyte activation, 2010, pp.185, 1037~1044
22. Newsholme EA, "Glutamine metabolism in lymphocytes : its biochemical, physiological and clinical importance", Q J Exp Physiol, 70, pp.473~489 (1985)
23. Buck MD, "Mitochondrial dynamics controls T cell fate through metabolic programming", Cell, 166, pp.63~76 (2016)
24. Ledderose C, "Mitochondria are gate-keepers of T cell function by producing the ATP that drives purinergic signaling", J Biol Chem, 289, pp.25936~25945 (2014)
25. Yi JS, "Electron transport complex I is required for CD8+ T cell function", J Immunol, 177, pp.852~862 (2006)
26. Amitrano AM, "Optical control of CD8+ T cell metabolism and effector functions", Front Immunol, 12, pp.666231~ (2021)
27. Pearce EL, "Enhancing CD8 T-cell memory by modulating fatty acid metabolism", Nature, 460, pp.103~107 (2009)
28. O’Sullivan D, "Memory CD8+ T cells use cell-intrinsic lipolysis to support the metabolic programming necessary for development", Immunity, 41, pp.75~88 (2014)
29. van der Windt GJ, "Mitochondrial respiratory capacity is a critical regulator of CD8+ T cell memory development", Immunity, 36, pp.68~78 (2012)
30. Marchetti P, "Mitochondrial spare respiratory capacity : mechanisms, regulation, and significance in non-transformed and cancer cells", FASEB J, 34, pp.13106~13124 (2020)
31. van der Windt GJ, "CD8 memory T cells have a bioenergetic advantage that underlies their rapid recall ability", Proc Natl Acad Sci U S A, 110, pp.14336~14341 (2013)
32. Almeida L, "Metabolic pathways in T cell activation and lineage differentiation", Semin Immunol, 28, pp.514~524 (2016)
33. Gerriets VA, "Metabolic programming and PDHK1 control CD4+ T cell subsets and inflammation", J Clin Invest, 125, pp.194~207 (2015)
34. Puleston DJ, "Polyamine metabolism is a central determinant of helper T cell lineage fidelity", Cell, 184, pp.4186~4202 (2021)
35. Dimeloe S, "The immune-metabolic basis of effector memory CD4+ T cell function under hypoxic conditions", J Immunol, 196, pp.106~114 (2016)
36. Scharping NE, "Mitochondrial stress induced by continuous stimulation under hypoxia rapidly drives T cell exhaustion", Nat Immunol, 22, pp.205~215 (2021)
37. Wherry EJ, "Molecular and cellular insights into T cell exhaustion", Nat Rev Immunol, 15, pp.486~499 (2015)
38. Wherry EJ, "Molecular signature of CD8+ T cell exhaustion during chronic viral infection", Immunity, 27, pp.670~684 (2007)
39. Bengsch B, "Bioenergetic insufficiencies due to metabolic alterations regulated by the inhibitory receptor PD-1 are an early driver of CD8+ T cell exhaustion", Immunity, 45, pp.358~373 (2016)
40. Ogando J, "PD-1 signaling affects cristae morphology and leads to mitochondrial dysfunction in human CD8+ T lymphocytes", J Immunother Cancer, 7, pp.151~ (2019)
41. Kishton RJ, "Metabolic regulation of T cell longevity and function in tumor immunotherapy", Cell Metab, 26, pp.94~109 (2017)
42. Clever D, "Oxygen sensing by T cells establishes an immunologically tolerant metastatic niche", Cell, 166, pp.1117~1131 (2016)
43. Siska PJ, "Suppression of Glut1 and Glucose metabolism by decreased Akt", mTORC1 signaling drives T cell impairment in B cell leukemia, 2016, pp.197, 2532~2540
44. Chamoto K, "Mitochondrial activation chemicals synergize with surface receptor PD-1 blockade for T cell-dependent antitumor activity", Proc Natl Acad Sci U S A, 114, pp.E761~E770 (2017)
45. Restifo NP, "Adoptive immunotherapy for cancer : harnessing the T cell response", Nat Rev Immunol, 12, pp.269~281 (2012)
46. Rohaan MW, "Adoptive cellular therapies : the current landscape", Virchows Arch, 474, pp.449~461 (2019)
47. Spiess PJ, "In vivo antitumor activity of tumor-infiltrating lymphocytes expanded in recombinant interleukin-2", J Natl Cancer Inst, 79, pp.1067~1075 (1987)
48. Rosenberg SA, "Durable complete responses in heavily pretreated patients with metastatic melanoma using T-cell transfer immunotherapy", Clin Cancer Res, 17, pp.4550~4557 (2011)
49. Gee AP, "GMP CAR-T cell production", Best Pract Res Clin Haematol, 31, pp.126~134 (2018)
50. Kessels HW, "Immunotherapy through TCR gene transfer", Nat Immunol, 2, pp.957~961 (2001)
51. Eshhar Z, "Specific activation and targeting of cytotoxic lymphocytes through chimeric single chains consisting of antibody-binding domains and the gamma or zeta subunits of the immunoglobulin and T-cell receptors", Proc Natl Acad Sci U S A, 90, pp.720~724 (1993)
52. Maher J, "Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRζ", CD28 receptor, 2002, pp.20, 70~75
53. Hong M, "Engineering CAR-T cells for next-generation cancer therapy", Cancer Cell, 38, pp.473~488 (2020)
54. Maus MV, "Antibody-modified T cells : CARs take the front seat for hematologic malignancies", Blood, 123, pp.2625~2635 (2014)
55. Hupperetz Cedric, "CAR T Cell Immunotherapy Beyond Haematological Malignancy", Immune Network, 22(1), pp.1~19 (2022), 대한면역학회[DOI]
56. Srivastava S, "Chimeric antigen receptor T cell therapy : challenges to bench-to-bedside efficacy", J Immunol, 200, pp.459~468 (2018)
57. Parry RV, "CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms", Mol Cell Biol, 25, pp.9543~9553 (2005)
58. 이지범, "Immune Checkpoint Inhibitors in 10 Years: Contribution of Basic Research and Clinical Application in Cancer Immunotherapy", Immune Network, 22(1), pp.1~22 (2022), 대한면역학회[DOI]
59. Bonaventura P, "Cold tumors : a therapeutic challenge for immunotherapy", Front Immunol, 10, pp.168~ (2019)
60. Pagès F, "In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer", J Clin Oncol, 27, pp.5944~5951 (2009)
61. Zhang L, "Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer", N Engl J Med, 348, pp.203~213 (2003)
62. Morgan RA, "Case report of a serious adverse event following the administration of T cells transduced with a chimeric antigen receptor recognizing ERBB2", Mol Ther, 18, pp.843~851 (2010)
63. Allavena P, "Chemokines in cancer related inflammation", Exp Cell Res, 317, pp.664~673 (2011)
64. Lanitis E, "Mechanisms regulating T-cell infiltration and activity in solid tumors", Ann Oncol, 28, pp.xii18~xii32 (2017)
65. Shulman Z, "Lymphocyte crawling and transendothelial migration require chemokine triggering of high-affinity LFA-1 integrin", Immunity, 30, pp.384~396 (2009)
66. Jiang H, "Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy", Nat Med, 22, pp.851~860 (2016)
67. Chen IX, "Blocking CXCR4 alleviates desmoplasia, increases T-lymphocyte infiltration, and improves immunotherapy in metastatic breast cancer", Proc Natl Acad Sci U S A, 116, pp.4558~4566 (2019)
68. Kishore M, "Regulatory T cell migration is dependent on glucokinase-mediated glycolysis", Immunity, 47, pp.875~889 (2017)
69. Marelli-Berg FM, "Metabolic regulation of leukocyte motility and migration", J Leukoc Biol, 104, pp.285~293 (2018)
70. Campello S, "Orchestration of lymphocyte chemotaxis by mitochondrial dynamics", J Exp Med, 203, pp.2879~2886 (2006)
71. Louis CU, "Antitumor activity and long-term fate of chimeric antigen receptor-positive T cells in patients with neuroblastoma", Blood, 118, pp.6050~6056 (2011)
72. Robbins PF, "Cutting edge : persistence of transferred lymphocyte clonotypes correlates with cancer regression in patients receiving cell transfer therapy", J Immunol, 173, pp.7125~7130 (2004)
73. Gattinoni L, "Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells", J Clin Invest, 115, pp.1616~1626 (2005)
74. Sukumar M, "Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor function", J Clin Invest, 123, pp.4479~4488 (2013)
75. Crompton JG, "Akt inhibition enhances expansion of potent tumor-specific lymphocytes with memory cell characteristics", Cancer Res, 75, pp.296~305 (2015)
76. Kawalekar OU, "Distinct signaling of coreceptors regulates specific metabolism pathways and impacts memory development in CAR T cells", Immunity, 44, pp.380~390 (2016)
77. Menk AV, "4-1BB costimulation induces T cell mitochondrial function and biogenesis enabling cancer immunotherapeutic responses", J Exp Med, 215, pp.1091~1100 (2018)
78. Araki K, "mTOR regulates memory CD8 T-cell differentiation", Nature, 460, pp.108~112 (2009)
79. Kagoya Y, "BET bromodomain inhibition enhances T cell persistence and function in adoptive immunotherapy models", J Clin Invest, 126, pp.3479~3494 (2016)
80. Geiger R, "L-arginine modulates T cell metabolism and enhances survival and anti-tumor activity", Cell, 167, pp.829~842 (2016)
81. Xu Y, "Closely related T-memory stem cells correlate with in vivo expansion of CAR. CD19-T cells and are preserved by IL-7 and IL-15", Blood, 123, pp.3750~3759 (2014)
82. Phan AT, "Constitutive glycolytic metabolism supports CD8+ T cell effector memory differentiation during viral infection", Immunity, 45, pp.1024~1037 (2016)
83. Alamino VA, "Antitumor responses stimulated by dendritic cells are improved by triiodothyronine binding to the thyroid hormone receptor β", Cancer Res, 75, pp.1265~1274 (2015)
84. Kroemer G, "Tumor cell metabolism : cancer’s Achilles’ heel", Cancer Cell, 13, pp.472~482 (2008)
85. Cham CM, "Glucose deprivation inhibits multiple key gene expression events and effector functions in CD8+ T cells", Eur J Immunol, 38, pp.2438~2450 (2008)
86. Maciver NJ, "Glucose metabolism in lymphocytes is a regulated process with significant effects on immune cell function and survival", J Leukoc Biol, 84, pp.949~957 (2008)
87. Zhang Y, "Enhancing CD8+ T cell fatty acid catabolism within a metabolically challenging tumor microenvironment increases the efficacy of melanoma immunotherapy", Cancer Cell, 32, pp.377~391 (2017)
88. Edwards DN, "Selective glutamine metabolism inhibition in tumor cells improves antitumor T lymphocyte activity in triple-negative breast cancer", J Clin Invest, 131, pp.e140100~ (2021)
89. Best SA, "Glutaminase inhibition impairs CD8 T cell activation in STK11-", Lkb1-deficient lung cancer, 2022, pp.34, 874~887
90. Carmona-Fontaine C, "Metabolic origins of spatial organization in the tumor microenvironment", Proc Natl Acad Sci U S A, 114, pp.2934~2939 (2017)
91. Chang CH, "Emerging concepts of T cell metabolism as a target of immunotherapy", Nat Immunol, 17, pp.364~368 (2016)
92. Scharping NE, "Efficacy of PD-1 blockade is potentiated by metformin-induced reduction of tumor hypoxia", Cancer Immunol Res, 5, pp.9~16 (2017)
93. Najjar YG, "Tumor cell oxidative metabolism as a barrier to PD-1 blockade immunotherapy in melanoma", JCI Insight, 4, pp.e124989~ (2019)
94. van Bruggen JA, "Chronic lymphocytic leukemia cells impair mitochondrial fitness in CD8+ T cells and impede CAR T-cell efficacy", Blood, 134, pp.44~58 (2019)
95. Budimir N, "Reversing T-cell exhaustion in cancer : lessons learned from PD-1", PD-L1 immune checkpoint blockade, 2022, pp.10, 146~153
96. Pauken KE, "Epigenetic stability of exhausted T cells limits durability of reinvigoration by PD-1 blockade", Science, 354, pp.1160~1165 (2016)
97. Ahmadzadeh M, "Tumor antigen-specific CD8 T cells infiltrating the tumor express high levels of PD-1 and are functionally impaired", Blood, 114, pp.1537~1544 (2009)
98. Jang SY, "Nicotinamide-induced mitophagy : event mediated by high NAD+", NADH ratio and SIRT1 protein activation, 2012, pp.287, 19304~19314
99. Finck BN, "PGC-1 coactivators : inducible regulators of energy metabolism in health and disease", J Clin Invest, 116, pp.615~622 (2006)

관련 논문AI추천